Vivodyne Bets Robotic Human-Tissue Labs Can Fix AI Drug Discovery's Data Gap
Biotech startup Vivodyne argues AI drug discovery is bottlenecked by a lack of causal human biological data, and has built HIVE modular robotic labs that grow 20 kinds of human tissue and autonomously dose and monitor th...
Risk:
[+0.01% ↑]
[0 days]
AGI:
[+0.01% ↑]
[0 days]